iPierian
Latest round
- Series B
Last raised
- Nov 2010
Total raised
- $60M
Investors
- 9
About iPierian
Founded in 2007, iPierian is a San Francisco-based biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPSC) technology and the discovery and development of innovative therapeutics using patient-derived cells as models of human disease.
Who invested in iPierian
9 investors across 7 rounds
See all investors in iPierian
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 8, 2010
Amount
$0.5M
Investors
Series B
Sep 8, 2010
Amount
$6M
Investors
Series B
Jul 8, 2010
Amount
$22M
Investors
Series A
Jul 3, 2009
Amount
$12M
Investors
Series A
May 31, 2009
Amount
$10M
Investors
Series A
Sep 8, 2008
Amount
$5M
Investors
Series A
Mar 31, 2008
Amount
$5.1M
Investors
Questions about iPierian
Who invested in iPierian?
iPierian has 9 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iPierian raised?
iPierian has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did iPierian last raise money?
iPierian's most recent round on record is a Series B, in Nov 2010.
What does iPierian do?
Founded in 2007, iPierian is a San Francisco-based biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPSC) technology and the discovery and development of innovative therapeutics using patient-derived cells as models of human disease.
Where is iPierian headquartered?
iPierian is headquartered in San Francisco, US.
Which VCs invest in companies like iPierian?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at iPierian's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like iPierian? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.